Literature DB >> 29271225

From the intestinal flora to the microbiome.

Juan José Sebastián Domingo1, Clara Sánchez Sánchez2.   

Abstract

In this article, the history of the microbiota is reviewed and the related concepts of the microbiota, microbiome, metagenome, pathobiont, dysbiosis, holobiont, phylotype and enterotype are defined. The most precise and current knowledge about the microbiota is presented and the metabolic, nutritional and immunomodulatory functions are reviewed. Some gastrointestinal diseases whose pathogenesis is associated with the intestinal microbiota, including inflammatory bowel disease, irritable bowel syndrome and celiac disease, among others, are briefly discussed. Finally, some prominent and promising data with regard to the fecal microbiota transplantation in certain digestive illness are discussed.

Entities:  

Mesh:

Year:  2018        PMID: 29271225     DOI: 10.17235/reed.2017.4947/2017

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  14 in total

1.  Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people.

Authors:  Shu-Chun Li; Yao Xiao; Ri-Tu Wu; Dan Xie; Huan-Hu Zhao; Gang-Yi Shen; En-Qi Wu
Journal:  J Microbiol       Date:  2021-05-15       Impact factor: 3.422

2.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

3.  The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.

Authors:  Zi-Yang Yi; Lin Chen; Yan Wang; Dan He; Di Zhao; Shui-Han Zhang; Rong Yu; Jian-Hua Huang
Journal:  Acta Diabetol       Date:  2022-07-20       Impact factor: 4.087

Review 4.  Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives.

Authors:  Lie Zheng; Yong-Yi Ji; Xin-Li Wen; Sheng-Lei Duan
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

Review 5.  Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases.

Authors:  Dan Wu; Huiying Wang; Lijun Xie; Fang Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

6.  The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.

Authors:  Chuantao Zhang; Xiang Cui; Lian Feng; Zhiyi Han; Deti Peng; Wenjun Fu; Yufeng Xing
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 7.  Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens.

Authors:  Sandra Salillas; Javier Sancho
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

Review 8.  Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders.

Authors:  José María Remes Troche; Enrique Coss Adame; Miguel Ángel Valdovinos Díaz; Octavio Gómez Escudero; María Eugenia Icaza Chávez; José Antonio Chávez-Barrera; Flora Zárate Mondragón; José Antonio Ruíz Velarde Velasco; Guillermo Rafael Aceves Tavares; Marco Antonio Lira Pedrín; Eduardo Cerda Contreras; Ramón Isaías Carmona Sánchez; Héctor Guerra López; Rodolfo Solana Ortiz
Journal:  Therap Adv Gastroenterol       Date:  2020-11-24       Impact factor: 4.409

9.  Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis.

Authors:  Yan Xiong; Lulu Liu; Xuchun Zhou; Youfei Wen; Ruonan Wang
Journal:  Clinics (Sao Paulo)       Date:  2020-11-11       Impact factor: 2.365

10.  Inhibitory Effect of a Microecological Preparation on Azoxymethane/Dextran Sodium Sulfate-Induced Inflammatory Colorectal Cancer in Mice.

Authors:  Weinan Yu; Jie Zhang; Zhewen Chen; Shuai Wang; Chuanxian Ruan; Wenli Zhou; Mingyong Miao; Hanping Shi
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.